Potential risk factors of ovarian cancer and analysis of CA125, a biomarker used for its monitoring and diagnosis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Potential risk factors of ovarian cancer and analysis of CA125, a biomarker used for its monitoring and diagnosis
Authors
Keywords
Ovarian cancer (OC), CA125, ELISA, Sensitivity, Chemotherapy
Journal
MOLECULAR BIOLOGY REPORTS
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2019-04-20
DOI
10.1007/s11033-019-04794-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Gynecological Cancer as a Second Malignancy in Patients With Breast Cancer
- (2017) Budhi Singh Yadav et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Hormonal risk factors for ovarian cancer in the Albanian case-control study
- (2017) Edlira Pajenga et al. Bosnian Journal of Basic Medical Sciences
- Clinical Use of Cancer Biomarkers in Epithelial Ovarian Cancer
- (2016) György Sölétormos et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Ovarian Cancer Screening Tests Don’t Pass Muster
- (2016) Rebecca Voelker JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical Significance of CA125 Level after the First Cycle of Chemotherapy on Survival of Patients with Advanced Ovarian Cancer
- (2016) Maria Lee et al. YONSEI MEDICAL JOURNAL
- Serum CA125 and HE4 levels as predictors for optimal interval surgery and platinum sensitivity after neoadjuvant platinum-based chemotherapy in patients with advanced epithelial ovarian cancer
- (2016) Aurélie Pelissier et al. Journal of Ovarian Research
- The diagnosis and pathological value of combined detection of HE4 and CA125 for patients with ovarian cancer
- (2016) Li-e Zheng et al. Open Medicine
- Polymorphisms of MUC16 (CA125) and MUC1 (CA15.3) in Relation to Ovarian Cancer Risk and Survival
- (2014) Kristina A. Williams et al. PLoS One
- Nadir CA-125 level as prognosis indicator of high-grade serous ovarian cancer
- (2013) Xia Xu et al. Journal of Ovarian Research
- Ovarian Cancer
- (2012) JESSICA HUNN et al. CLINICAL OBSTETRICS AND GYNECOLOGY
- Tumor markers for early detection of ovarian cancer
- (2010) Juan Ren et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Clinical Utility of CA-125 for Maintenance Therapy in the Treatment of Advanced Stage Ovarian Carcinoma
- (2010) John P. Micha et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- CA-125 change after chemotherapy in prediction of treatment outcome among advanced mucinous and clear cell epithelial ovarian cancers
- (2009) Chunqiao Tian et al. CANCER
- The prognostic value of pretreatment CA 125 in patients with advanced ovarian carcinoma
- (2009) Kristin K. Zorn et al. CANCER
- Role of CA125 in predicting ovarian cancer survival - a review of the epidemiological literature
- (2009) Digant Gupta et al. Journal of Ovarian Research
- Can the preoperative Ca-125 level predict optimal cytoreduction in patients with advanced ovarian carcinoma? A single institution cohort study
- (2008) George Vorgias et al. GYNECOLOGIC ONCOLOGY
- Nadir CA-125 concentration in the normal range as an independent prognostic factor for optimally treated advanced epithelial ovarian cancer
- (2007) A. Prat et al. ANNALS OF ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now